Notable Labs, Ltd. (NTBL)

USD 0.25

(-27.68%)

Total Assets Summary of Notable Labs, Ltd.

  • Notable Labs, Ltd.'s latest annual total assets in 2023 was 19.54 Million USD , up 254.58% from previous year.
  • Notable Labs, Ltd.'s latest quarterly total assets in 2024 Q1 was 15.59 Million USD , down 0.0% from previous quarter.
  • Notable Labs, Ltd. reported annual total assets of 5.51 Million USD in 2022, down -35.07% from previous year.
  • Notable Labs, Ltd. reported annual total assets of 8.48 Million USD in 2021, down -79.65% from previous year.
  • Notable Labs, Ltd. reported quarterly total assets of 11 Million USD for 2024 Q2, down -29.45% from previous quarter.
  • Notable Labs, Ltd. reported quarterly total assets of 19.54 Million USD for 2023 FY, up 254.58% from previous quarter.

Annual Total Assets Chart of Notable Labs, Ltd. (2023 - 2015)

Historical Annual Total Assets of Notable Labs, Ltd. (2023 - 2015)

Year Total Assets Total Assets Growth
2023 19.54 Million USD 254.58%
2022 5.51 Million USD -35.07%
2021 8.48 Million USD -79.65%
2020 41.7 Million USD -14.89%
2019 49 Million USD -19.24%
2018 60.67 Million USD -7.63%
2017 65.68 Million USD 38.95%
2016 47.27 Million USD 20.48%
2015 39.23 Million USD 0.0%

Peer Total Assets Comparison of Notable Labs, Ltd.

Name Total Assets Total Assets Difference
Sangamo Therapeutics, Inc. 165.32 Million USD 88.18%
IDEAYA Biosciences, Inc. 649.31 Million USD 96.991%
Eton Pharmaceuticals, Inc. 31.74 Million USD 38.434%
Autolus Therapeutics plc 375.38 Million USD 94.794%
Greenwich LifeSciences, Inc. 6.99 Million USD -179.364%
Enlivex Therapeutics Ltd. 36.83 Million USD 46.944%
Shattuck Labs, Inc. 159.56 Million USD 87.754%
LENZ Therapeutics, Inc. 188.45 Million USD 89.631%
CervoMed Inc. 9.97 Million USD -95.948%
Rocket Pharmaceuticals, Inc. 566.34 Million USD 96.55%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD 30.883%
Aptose Biosciences Inc. 12.92 Million USD -51.216%
Precision BioSciences, Inc. 159.78 Million USD 87.77%
Dyadic International, Inc. 8.21 Million USD -137.747%
TScan Therapeutics, Inc. 272.14 Million USD 92.82%
Intensity Therapeutics, Inc. 17.29 Million USD -12.986%
Nektar Therapeutics 398.03 Million USD 95.091%
CytomX Therapeutics, Inc. 205.15 Million USD 90.475%
VYNE Therapeutics Inc. 97.68 Million USD 79.996%
EyePoint Pharmaceuticals, Inc. 355.18 Million USD 94.498%
Leap Therapeutics, Inc. 72.82 Million USD 73.167%
Adaptive Biotechnologies Corporation 661.13 Million USD 97.044%
GRI Bio, Inc. 2.95 Million USD -561.062%
Xenetic Biosciences, Inc. 10.6 Million USD -84.258%
Tenaya Therapeutics, Inc. 170.51 Million USD 88.54%
NeuroSense Therapeutics Ltd. 3.17 Million USD -515.271%
Psyence Biomedical Ltd. 1.13 Million USD -1625.994%
IGM Biosciences, Inc. 423.41 Million USD 95.385%
INmune Bio, Inc. 57 Million USD 65.718%
Opthea Limited 188.79 Million USD 89.649%
Milestone Pharmaceuticals Inc. 75.22 Million USD 74.024%
Omega Therapeutics, Inc. 204.36 Million USD 90.438%
Verastem, Inc. 149.71 Million USD 86.948%
Abeona Therapeutics Inc. 64 Million USD 69.468%
Pliant Therapeutics, Inc. 512.15 Million USD 96.185%
Tonix Pharmaceuticals Holding Corp. 154.45 Million USD 87.349%
Ligand Pharmaceuticals Incorporated 833.06 Million USD 97.654%
NextCure, Inc. 129.41 Million USD 84.901%
Inhibikase Therapeutics, Inc. 14.5 Million USD -34.704%
Organovo Holdings, Inc. 6.34 Million USD -207.781%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -353.533%
Arvinas, Inc. 1.3 Billion USD 98.502%
Ovid Therapeutics Inc. 144.02 Million USD 86.432%
CASI Pharmaceuticals, Inc. 75.26 Million USD 74.038%
Rani Therapeutics Holdings, Inc. 57.91 Million USD 66.26%
Centessa Pharmaceuticals plc 362.96 Million USD 94.616%
Arcturus Therapeutics Holdings Inc. 429.4 Million USD 95.449%
Syros Pharmaceuticals, Inc. 168.17 Million USD 88.38%
Senti Biosciences, Inc. 119.48 Million USD 83.646%
BioRestorative Therapies, Inc. 12.61 Million USD -54.943%
Apollomics, Inc. 55.38 Million USD 64.719%
PureTech Health plc 693.97 Million USD 97.184%
Oncternal Therapeutics, Inc. 36.72 Million USD 46.797%
Barinthus Biotherapeutics plc 214.5 Million USD 90.89%
Kymera Therapeutics, Inc. 575.75 Million USD 96.606%
Synaptogenix, Inc. 31.11 Million USD 37.195%
ChromaDex Corporation 54.96 Million USD 64.448%
Beam Therapeutics Inc. 1.45 Billion USD 98.661%
Monopar Therapeutics Inc. 7.34 Million USD -166.039%
Akebia Therapeutics, Inc. 241.7 Million USD 91.915%
Nurix Therapeutics, Inc. 364.53 Million USD 94.64%
Apellis Pharmaceuticals, Inc. 788.73 Million USD 97.522%
Dermata Therapeutics, Inc. 7.97 Million USD -144.917%
Gritstone bio, Inc. 177.76 Million USD 89.008%
Mesoblast Limited 669.15 Million USD 97.08%
Virpax Pharmaceuticals, Inc. 9.62 Million USD -102.953%
Xeris Biopharma Holdings, Inc. 340.79 Million USD 94.266%
Fate Therapeutics, Inc. 506.21 Million USD 96.14%
MediWound Ltd. 66.45 Million USD 70.597%
BioXcel Therapeutics, Inc. 73.7 Million USD 73.486%
Fortress Biotech, Inc. 167.52 Million USD 88.336%
Fractyl Health, Inc. Common Stock 76.21 Million USD 74.36%
Achilles Therapeutics plc 161.45 Million USD 87.897%
Seres Therapeutics, Inc. 358.6 Million USD 94.551%
Checkpoint Therapeutics, Inc. 5.37 Million USD -263.351%
Atossa Therapeutics, Inc. 96.25 Million USD 79.698%
Zai Lab Limited 1.03 Billion USD 98.114%
Fresh Tracks Therapeutics, Inc. 11.58 Million USD -68.66%
Lyell Immunopharma, Inc. 750.02 Million USD 97.395%
Vanda Pharmaceuticals Inc. 648.44 Million USD 96.986%
Tarsus Pharmaceuticals, Inc. 266.22 Million USD 92.66%
InMed Pharmaceuticals Inc. 11.82 Million USD -65.283%
FibroGen, Inc. 423.52 Million USD 95.386%
Celcuity Inc. 191.21 Million USD 89.781%
SeaStar Medical Holding Corporation 3.51 Million USD -456.248%
ContextLogic Inc. 423 Million USD 95.38%
GH Research PLC 226.3 Million USD 91.365%
HOOKIPA Pharma Inc. 161.33 Million USD 87.888%
Cyclacel Pharmaceuticals, Inc. 8.8 Million USD -121.931%
ImmuCell Corporation 43.8 Million USD 55.394%
Amylyx Pharmaceuticals, Inc. 517.45 Million USD 96.224%
Amarin Corporation plc 831.68 Million USD 97.65%
TG Therapeutics, Inc. 329.58 Million USD 94.071%
Aptevo Therapeutics Inc. 24.84 Million USD 21.339%
Jasper Therapeutics, Inc. 95.38 Million USD 79.512%
Foghorn Therapeutics Inc. 285.91 Million USD 93.165%
Y-mAbs Therapeutics, Inc. 127.86 Million USD 84.718%
Aptorum Group Limited 20.64 Million USD 5.325%
Ultragenyx Pharmaceutical Inc. 1.49 Billion USD 98.689%
BioCryst Pharmaceuticals, Inc. 516.96 Million USD 96.22%
Chemomab Therapeutics Ltd. 22.15 Million USD 11.783%
Arrowhead Pharmaceuticals, Inc. 765.55 Million USD 97.447%
TransCode Therapeutics, Inc. 5.16 Million USD -277.991%
RAPT Therapeutics, Inc. 173.32 Million USD 88.726%
Ardelyx, Inc. 297.57 Million USD 93.433%
Ainos, Inc. 31.84 Million USD 38.631%
Lyra Therapeutics, Inc. 142.6 Million USD 86.297%
Prothena Corporation plc 696.38 Million USD 97.194%
HilleVax, Inc. 344.43 Million USD 94.327%
Adaptimmune Therapeutics plc 282.61 Million USD 93.086%
Celularity Inc. 143.88 Million USD 86.419%
Rallybio Corporation 115.62 Million USD 83.099%
Cue Biopharma, Inc. 61.53 Million USD 68.242%
Omeros Corporation 378.26 Million USD 94.834%
Humacyte, Inc. 128.22 Million USD 84.76%
Immunocore Holdings plc 597 Million USD 96.727%
Cocrystal Pharma, Inc. 31.25 Million USD 37.487%
Blueprint Medicines Corporation 1.04 Billion USD 98.138%
IO Biotech, Inc. 150.71 Million USD 87.035%
MEI Pharma, Inc. 41.37 Million USD 52.771%
GT Biopharma, Inc. 14.1 Million USD -38.5%
Cabaletta Bio, Inc. 253.65 Million USD 92.296%
Summit Therapeutics Inc. 202.94 Million USD 90.371%
Alaunos Therapeutics, Inc. 8.26 Million USD -136.488%
Marinus Pharmaceuticals, Inc. 170.9 Million USD 88.566%
Scholar Rock Holding Corporation 311.03 Million USD 93.717%
Pulmatrix, Inc. 33.95 Million USD 42.455%
Elicio Therapeutics, Inc. 27.14 Million USD 28.015%
X4 Pharmaceuticals, Inc. 147.25 Million USD 86.73%
Vigil Neuroscience, Inc. 140.85 Million USD 86.127%
Acelyrin, Inc. 742.69 Million USD 97.369%
Intellia Therapeutics, Inc. 1.3 Billion USD 98.498%
Cytokinetics, Incorporated 824.31 Million USD 97.629%
Vor Biopharma Inc. 209.82 Million USD 90.687%
Evogene Ltd. 51.1 Million USD 61.76%
Replimune Group, Inc. 487.72 Million USD 95.993%
Applied Therapeutics, Inc. 54.83 Million USD 64.363%
PDS Biotechnology Corporation 59.39 Million USD 67.097%
Hoth Therapeutics, Inc. 9.52 Million USD -105.257%
BridgeBio Pharma, Inc. 546.38 Million USD 96.424%
AEON Biopharma, Inc. 6.84 Million USD -185.478%
BioLineRx Ltd. 63.92 Million USD 69.431%
Galectin Therapeutics Inc. 28.2 Million USD 30.706%
Atai Life Sciences N.V. 293.47 Million USD 93.342%
Aerovate Therapeutics, Inc. 127.41 Million USD 84.664%
VistaGen Therapeutics, Inc. 123.65 Million USD 84.197%
Zentalis Pharmaceuticals, Inc. 562.02 Million USD 96.523%
Sagimet Biosciences Inc. 96.71 Million USD 79.796%
MediciNova, Inc. 66.26 Million USD 70.513%
Praxis Precision Medicines, Inc. 87.94 Million USD 77.781%
MiMedx Group, Inc. 239.04 Million USD 91.825%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -337.907%
Axsome Therapeutics, Inc. 588.23 Million USD 96.678%
PTC Therapeutics, Inc. 1.9 Billion USD 98.973%
Mereo BioPharma Group plc 66.49 Million USD 70.615%
Syndax Pharmaceuticals, Inc. 612.88 Million USD 96.812%
NRx Pharmaceuticals, Inc. 7.31 Million USD -167.136%
Dyne Therapeutics, Inc. 165.08 Million USD 88.163%
BriaCell Therapeutics Corp. 5.87 Million USD -232.768%
Allakos Inc. 243.61 Million USD 91.979%
scPharmaceuticals Inc. 94.47 Million USD 79.317%
Fulcrum Therapeutics, Inc. 257.69 Million USD 92.417%
Corcept Therapeutics Incorporated 621.51 Million USD 96.856%
NLS Pharmaceutics AG 1.84 Million USD -958.192%
Precigen, Inc. 151.04 Million USD 87.063%
XOMA Corporation 234.3 Million USD 91.66%
Kezar Life Sciences, Inc. 221.23 Million USD 91.167%
Incyte Corporation 6.78 Billion USD 99.712%
Alzamend Neuro, Inc. 631.58 Thousand USD -2993.947%
Cara Therapeutics, Inc. 125.84 Million USD 84.472%
Aligos Therapeutics, Inc. 153.9 Million USD 87.303%
Seer, Inc. 436.26 Million USD 95.521%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -3.262%
CRISPR Therapeutics AG 2.22 Billion USD 99.124%
Akero Therapeutics, Inc. 580.27 Million USD 96.632%
Eliem Therapeutics, Inc. 110.46 Million USD 82.311%
EyeGate Pharmaceuticals, Inc. 15.15 Million USD -28.919%
Akari Therapeutics, Plc 4.35 Million USD -348.703%
Novavax, Inc. 1.85 Billion USD 98.947%
Lexaria Bioscience Corp. 3.08 Million USD -533.628%
UroGen Pharma Ltd. 178.31 Million USD 89.041%
Sutro Biopharma, Inc. 470.73 Million USD 95.849%
Entera Bio Ltd. 11.76 Million USD -66.094%
Lisata Therapeutics, Inc. 54.69 Million USD 64.272%
Stoke Therapeutics, Inc. 228.34 Million USD 91.442%
Chimerix, Inc. 212.77 Million USD 90.816%
Reneo Pharmaceuticals, Inc. 107.43 Million USD 81.811%
Phathom Pharmaceuticals, Inc. 413.84 Million USD 95.278%
Outlook Therapeutics, Inc. 32.3 Million USD 39.503%
Jazz Pharmaceuticals plc 11.39 Billion USD 99.828%
AnaptysBio, Inc. 452.38 Million USD 95.68%
Aprea Therapeutics, Inc. 22.65 Million USD 13.727%
Portage Biotech Inc. 7.77 Million USD -151.202%
Olema Pharmaceuticals, Inc. 276.94 Million USD 92.944%
PMV Pharmaceuticals, Inc. 252.15 Million USD 92.25%
OKYO Pharma Limited 1.54 Million USD -1167.855%
Qualigen Therapeutics, Inc. 2.03 Million USD -861.073%
Cadrenal Therapeutics, Inc. Common Stock 8.51 Million USD -129.375%
Processa Pharmaceuticals, Inc. 5.78 Million USD -237.691%
AbCellera Biologics Inc. 1.48 Billion USD 98.687%
Genprex, Inc. 10.67 Million USD -83.129%
Neumora Therapeutics, Inc. Common Stock 496.19 Million USD 96.062%
NLS Pharmaceutics AG 1.84 Million USD -958.192%
Virios Therapeutics, Inc. 4.16 Million USD -369.122%
Daré Bioscience, Inc. 21.28 Million USD 8.182%
Titan Pharmaceuticals, Inc. 8.08 Million USD -141.665%
Bicycle Therapeutics plc 595.34 Million USD 96.718%
Revolution Medicines, Inc. Warrant 2.08 Billion USD 99.064%
Protagonist Therapeutics, Inc. 357.95 Million USD 94.541%
Erasca, Inc. 395.29 Million USD 95.057%
bluebird bio, Inc. 619.16 Million USD 96.844%
Pieris Pharmaceuticals, Inc. 38.68 Million USD 49.48%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 99.714%
DBV Technologies S.A. 182.98 Million USD 89.321%
Fortress Biotech, Inc. 167.52 Million USD 88.336%
Avidity Biosciences, Inc. 628.55 Million USD 96.891%
CorMedix Inc. 82.05 Million USD 76.187%
Travere Therapeutics, Inc. 788.91 Million USD 97.523%
Sensei Biotherapeutics, Inc. 74.37 Million USD 73.726%
Orchestra BioMed Holdings, Inc. 95.21 Million USD 79.476%
Spruce Biosciences, Inc. 103.94 Million USD 81.201%
Celldex Therapeutics, Inc. 465.62 Million USD 95.803%
Cartesian Therapeutics, Inc. 305.05 Million USD 93.594%
Cogent Biosciences, Inc. 313.43 Million USD 93.766%
Onconetix, Inc. 88.82 Million USD 78.0%
Ocuphire Pharma, Inc. 53.94 Million USD 63.778%
Prime Medicine, Inc. 193.85 Million USD 89.92%
Adagene Inc. 115.72 Million USD 83.115%
Inhibrx Biosciences, Inc. 307.89 Million USD 93.653%
GlycoMimetics, Inc. 45.31 Million USD 56.879%
Maravai LifeSciences Holdings, Inc. 1.48 Billion USD 98.686%
Verve Therapeutics, Inc. 752.68 Million USD 97.404%
Voyager Therapeutics, Inc. 351.28 Million USD 94.437%
SciSparc Ltd. 11.18 Million USD -74.754%
Revelation Biosciences, Inc. 12.21 Million USD -60.007%
Minerva Neurosciences, Inc. 56.9 Million USD 65.658%
Astria Therapeutics, Inc. 254.66 Million USD 92.327%
Spero Therapeutics, Inc. 182.39 Million USD 89.286%
Tevogen Bio Holdings Inc. 17.03 Million USD -14.695%
Arcutis Biotherapeutics, Inc. 341.36 Million USD 94.276%
Marker Therapeutics, Inc. 17.12 Million USD -14.092%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 99.49%
Artelo Biosciences, Inc. 20.42 Million USD 4.323%
2seventy bio, Inc. 565.42 Million USD 96.544%
ADMA Biologics, Inc. 329.18 Million USD 94.064%
Clene Inc. 52.34 Million USD 62.666%
Capricor Therapeutics, Inc. 58.73 Million USD 66.73%
Boundless Bio, Inc. Common Stock 129.89 Million USD 84.956%
Recursion Pharmaceuticals, Inc. 653.69 Million USD 97.011%
Citius Pharmaceuticals, Inc. 103.61 Million USD 81.14%
Contineum Therapeutics, Inc. Class A Common Stock 130.38 Million USD 85.013%
Absci Corporation 234.48 Million USD 91.666%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 99.941%
Surrozen, Inc. 46.08 Million USD 57.593%
Caribou Biosciences, Inc. 440.96 Million USD 95.569%
Janux Therapeutics, Inc. 380.4 Million USD 94.863%
Cingulate Inc. 3.49 Million USD -459.684%
Galmed Pharmaceuticals Ltd. 16.62 Million USD -17.512%
Tenax Therapeutics, Inc. 11.68 Million USD -67.237%
Jaguar Health, Inc. 50.76 Million USD 61.505%
Terns Pharmaceuticals, Inc. 268.51 Million USD 92.723%
ACADIA Pharmaceuticals Inc. 748.95 Million USD 97.391%
Kronos Bio, Inc. 213.27 Million USD 90.838%
Innoviva, Inc. 1.24 Billion USD 98.429%
Bolt Biotherapeutics, Inc. 159.78 Million USD 87.77%
Entrada Therapeutics, Inc. 469.19 Million USD 95.835%
ZyVersa Therapeutics, Inc. 22.11 Million USD 11.636%
Soligenix, Inc. 9.79 Million USD -99.452%
AlloVir, Inc. 190.79 Million USD 89.758%
Century Therapeutics, Inc. 360.69 Million USD 94.582%
ORIC Pharmaceuticals, Inc. 254.68 Million USD 92.327%
Kura Oncology, Inc. 448.93 Million USD 95.647%
Ocean Biomedical, Inc. 110.91 Million USD 82.381%
Mineralys Therapeutics, Inc. 251.63 Million USD 92.234%
Eterna Therapeutics Inc. 49.13 Million USD 60.228%
SELLAS Life Sciences Group, Inc. 6.4 Million USD -205.185%
Heron Therapeutics, Inc. 222.5 Million USD 91.218%
SAB Biotherapeutics, Inc. 83.94 Million USD 76.721%
Pasithea Therapeutics Corp. 26.11 Million USD 25.179%
Entero Therapeutics, Inc. 6.88 Million USD -183.894%
HCW Biologics Inc. 28.51 Million USD 31.468%
C4 Therapeutics, Inc. 376.45 Million USD 94.809%
Atara Biotherapeutics, Inc. 165.5 Million USD 88.193%
Coherus BioSciences, Inc. 629.6 Million USD 96.896%
Lantern Pharma Inc. 43.64 Million USD 55.23%
Histogen Inc. 19.07 Million USD -2.454%
Surrozen, Inc. 46.08 Million USD 57.593%
Eledon Pharmaceuticals, Inc. 125.89 Million USD 84.478%
Kodiak Sciences Inc. 479.37 Million USD 95.924%
MoonLake Immunotherapeutics 526.54 Million USD 96.289%
Hepion Pharmaceuticals, Inc. 18.09 Million USD -7.995%
Adverum Biotechnologies, Inc. 173.01 Million USD 88.705%
Avalo Therapeutics, Inc. 20.99 Million USD 6.917%
Moderna, Inc. 18.42 Billion USD 99.894%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 99.346%
Turnstone Biologics Corp. 112.81 Million USD 82.679%
Immix Biopharma, Inc. 19.92 Million USD 1.928%
Tiziana Life Sciences Ltd 12.18 Million USD -60.382%
Aurinia Pharmaceuticals Inc. 548.06 Million USD 96.435%
Exelixis, Inc. 2.94 Billion USD 99.336%
Monte Rosa Therapeutics, Inc. 303.75 Million USD 93.567%
Wave Life Sciences Ltd. 274.94 Million USD 92.893%
Conduit Pharmaceuticals Inc. 7.22 Million USD -170.501%
Alkermes plc 2.13 Billion USD 99.085%
Jasper Therapeutics, Inc. 95.38 Million USD 79.512%
Arcellx, Inc. 825.13 Million USD 97.632%
ESSA Pharma Inc. 149.12 Million USD 86.896%
TNF Pharmaceuticals, Inc. 17.86 Million USD -9.398%
Avid Bioservices, Inc. 336.55 Million USD 94.194%
Insmed Incorporated 1.32 Billion USD 98.531%
Cardiff Oncology, Inc. 81.63 Million USD 76.064%
Enanta Pharmaceuticals, Inc. 462.27 Million USD 95.773%
Moolec Science SA 24.05 Million USD 18.753%
RenovoRx, Inc. 1.46 Million USD -1232.947%
Acumen Pharmaceuticals, Inc. 310.12 Million USD 93.699%
Geron Corporation 394.07 Million USD 95.041%
LAVA Therapeutics N.V. 101.71 Million USD 80.788%
Verrica Pharmaceuticals Inc. 81.59 Million USD 76.052%
Royalty Pharma plc 16.38 Billion USD 99.881%
OmniAb, Inc. 401.98 Million USD 95.139%
Alector, Inc. 621.82 Million USD 96.857%
Atea Pharmaceuticals, Inc. 594.96 Million USD 96.716%
Mersana Therapeutics, Inc. 226.06 Million USD 91.356%
Humacyte, Inc. 128.22 Million USD 84.76%
Structure Therapeutics Inc. 482.01 Million USD 95.946%
Revance Therapeutics, Inc. 478.45 Million USD 95.916%
89bio, Inc. 596.26 Million USD 96.723%
Avenue Therapeutics, Inc. 1.85 Million USD -956.27%
Aura Biosciences, Inc. 255.07 Million USD 92.339%
Immunic, Inc. 54.29 Million USD 64.012%
Veracyte, Inc. 1.13 Billion USD 98.283%
Genelux Corporation 27.89 Million USD 29.943%
Trevi Therapeutics, Inc. 89.4 Million USD 78.143%
Adial Pharmaceuticals, Inc. 4.73 Million USD -312.553%
Sonnet BioTherapeutics Holdings, Inc. 5.42 Million USD -259.906%
Immunovant, Inc. 666.71 Million USD 97.069%
Vericel Corporation 353.65 Million USD 94.475%
Fortrea Holdings Inc. 4.35 Billion USD 99.552%
KalVista Pharmaceuticals, Inc. 235.4 Million USD 91.699%
XBiotech Inc. 227.24 Million USD 91.401%
Agenus Inc. 313.91 Million USD 93.775%
Acasti Pharma Inc. 73.3 Million USD 73.341%
Kiora Pharmaceuticals, Inc. 13.71 Million USD -42.512%
MiNK Therapeutics, Inc. 4.55 Million USD -329.257%
Pasithea Therapeutics Corp. 26.11 Million USD 25.179%
Theravance Biopharma, Inc. 381.99 Million USD 94.885%
Metagenomi, Inc. Common Stock 364.84 Million USD 94.644%
NeuroBo Pharmaceuticals, Inc. 22.78 Million USD 14.222%
Gain Therapeutics, Inc. 18.6 Million USD -5.006%
Tempest Therapeutics, Inc. 51.6 Million USD 62.132%
Sol-Gel Technologies Ltd. 45.28 Million USD 56.851%
Rhythm Pharmaceuticals, Inc. 332.74 Million USD 94.127%
United Therapeutics Corporation 7.16 Billion USD 99.727%
Creative Medical Technology Holdings, Inc. 10.71 Million USD -82.367%
BriaCell Therapeutics Corp. 5.87 Million USD -232.768%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -353.533%
Silo Pharma, Inc. 7.74 Million USD -152.268%
Telomir Pharmaceuticals, Inc. Common Stock 4.77 Million USD -309.341%
Pharming Group N.V. 462.85 Million USD 95.778%
XOMA Corporation 234.3 Million USD 91.66%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -3.262%
Bionomics Limited 27.64 Million USD 29.325%
Alpha Tau Medical Ltd. 107.38 Million USD 81.803%
Pyxis Oncology, Inc. 173.72 Million USD 88.752%
uniQure N.V. 831.68 Million USD 97.65%
Xilio Therapeutics, Inc. 60.92 Million USD 67.927%
Cassava Sciences, Inc. 151.66 Million USD 87.116%
60 Degrees Pharmaceuticals, Inc. 7.78 Million USD -151.048%
Windtree Therapeutics, Inc. 32.4 Million USD 39.699%
Poseida Therapeutics, Inc. 273.88 Million USD 92.865%
Pluri Inc. 39.52 Million USD 50.563%
Anebulo Pharmaceuticals, Inc. 4.07 Million USD -379.756%
MeiraGTx Holdings plc 458.16 Million USD 95.735%
Cidara Therapeutics, Inc. 68.53 Million USD 71.485%
ProMIS Neurosciences, Inc. 18.04 Million USD -8.291%
CalciMedica, Inc. 12.18 Million USD -60.369%
Sana Biotechnology, Inc. 565.29 Million USD 96.543%
Amicus Therapeutics, Inc. 777.88 Million USD 97.488%
Salarius Pharmaceuticals, Inc. 6.58 Million USD -196.682%
Alpha Tau Medical Ltd. 107.38 Million USD 81.803%
Adlai Nortye Ltd. American Depositary Shares 130.18 Million USD 84.99%
Nutriband Inc. 7.51 Million USD -159.952%
Protara Therapeutics, Inc. 78.95 Million USD 75.25%
Compugen Ltd. 121.33 Million USD 83.895%
Roivant Sciences Ltd. 7.22 Billion USD 99.729%
ProKidney Corp. 420.55 Million USD 95.353%
Protagenic Therapeutics, Inc. 4.32 Million USD -351.985%
Elevai Labs, Inc. Common Stock 5.18 Million USD -276.518%
Tango Therapeutics, Inc. 402.56 Million USD 95.146%
Renovaro Biosciences Inc. 163.12 Million USD 88.021%
Zevra Therapeutics, Inc. 172.32 Million USD 88.661%
Benitec Biopharma Inc. 52.21 Million USD 62.572%
GeoVax Labs, Inc. 9.28 Million USD -110.498%
Biomea Fusion, Inc. 199.92 Million USD 90.226%
Cullinan Oncology, Inc. 485.09 Million USD 95.972%
4D Molecular Therapeutics, Inc. 339.89 Million USD 94.251%
Kiniksa Pharmaceuticals, Ltd. 526.32 Million USD 96.287%
Nuvectis Pharma, Inc. 19.18 Million USD -1.856%
Spyre Therapeutics, Inc. 341.85 Million USD 94.284%
Ventyx Biosciences, Inc. 277.69 Million USD 92.963%
Imunon, Inc. 21.91 Million USD 10.845%
BioAtla, Inc. 119.65 Million USD 83.669%
Allogene Therapeutics, Inc. 642.83 Million USD 96.96%
Larimar Therapeutics, Inc. 95.93 Million USD 79.631%
Zura Bio Limited 100.84 Million USD 80.622%
aTyr Pharma, Inc. 122.06 Million USD 83.992%
Madrigal Pharmaceuticals, Inc. 640.54 Million USD 96.949%
Viridian Therapeutics, Inc. 490.42 Million USD 96.015%
Galecto, Inc. 38.22 Million USD 48.882%
Tevogen Bio Holdings Inc. 17.03 Million USD -14.695%
Halozyme Therapeutics, Inc. 1.73 Billion USD 98.873%
Lexicon Pharmaceuticals, Inc. 229.42 Million USD 91.483%
PolyPid Ltd. 15.37 Million USD -27.121%
Aileron Therapeutics, Inc. 119.28 Million USD 83.618%
Forte Biosciences, Inc. 38.98 Million USD 49.869%
Xencor, Inc. 952.69 Million USD 97.949%
Coeptis Therapeutics Holdings, Inc. 8.07 Million USD -142.111%
Lexaria Bioscience Corp. 3.08 Million USD -533.628%
Instil Bio, Inc. 325.63 Million USD 93.999%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -337.907%
OncoCyte Corporation 74.89 Million USD 73.908%
Elevation Oncology, Inc. 89.09 Million USD 78.066%
Purple Biotech Ltd. 44.3 Million USD 55.891%
CollPlant Biotechnologies Ltd. 34.12 Million USD 42.739%
MacroGenics, Inc. 306.82 Million USD 93.631%
Verona Pharma plc 308.12 Million USD 93.658%
Tharimmune, Inc. 10.94 Million USD -78.515%
Apogee Therapeutics, Inc. 401.4 Million USD 95.132%
enGene Holdings Inc. Warrants 86.95 Million USD 77.528%
Aditxt, Inc. 44.57 Million USD 56.165%
XTL Biopharmaceuticals Ltd. 2.42 Million USD -705.482%
Savara Inc. 177.56 Million USD 88.995%
Curis, Inc. 77.28 Million USD 74.715%
Carmell Therapeutics Corporation 63.94 Million USD 69.443%
Achieve Life Sciences, Inc. 19.37 Million USD -0.878%
BeiGene, Ltd. 5.8 Billion USD 99.663%
Protagenic Therapeutics, Inc. 4.32 Million USD -351.985%
Vincerx Pharma, Inc. 18.21 Million USD -7.268%
Plus Therapeutics, Inc. 11.38 Million USD -71.593%
Acrivon Therapeutics, Inc. Common Stock 138.26 Million USD 85.867%
Rigel Pharmaceuticals, Inc. 117.22 Million USD 83.33%
Adicet Bio, Inc. 207.29 Million USD 90.573%
Estrella Immunopharma, Inc. 4.45 Million USD -338.711%
Quantum-Si incorporated 298.25 Million USD 93.448%
Acurx Pharmaceuticals, Inc. 7.7 Million USD -153.479%
Generation Bio Co. 374.75 Million USD 94.786%
Black Diamond Therapeutics, Inc. 158.56 Million USD 87.677%
Invivyd, Inc. 229.18 Million USD 91.474%
Relay Therapeutics, Inc. 843.98 Million USD 97.685%
Quoin Pharmaceuticals, Ltd. 12.16 Million USD -60.576%
Moolec Science SA 24.05 Million USD 18.753%
Clearside Biomedical, Inc. 34.01 Million USD 42.557%
Longboard Pharmaceuticals, Inc. 50.69 Million USD 61.455%
Relmada Therapeutics, Inc. 97.55 Million USD 79.969%
ALX Oncology Holdings Inc. 242.55 Million USD 91.944%
Vir Biotechnology, Inc. 1.96 Billion USD 99.003%
Evaxion Biotech A/S 12.88 Million USD -51.614%
Ocular Therapeutix, Inc. 252.06 Million USD 92.247%
Tyra Biosciences, Inc. 225.85 Million USD 91.348%
Unity Biotechnology, Inc. 65.69 Million USD 70.253%
Connect Biopharma Holdings Limited 125.89 Million USD 84.478%
Clearmind Medicine Inc. 4.32 Million USD -351.879%
Aadi Bioscience, Inc. 132.42 Million USD 85.243%
Catalyst Pharmaceuticals, Inc. 471.9 Million USD 95.859%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -128.266%
Viking Therapeutics, Inc. 368.49 Million USD 94.697%
Keros Therapeutics, Inc. 370.02 Million USD 94.719%
Crinetics Pharmaceuticals, Inc. 635.35 Million USD 96.924%
ImmunityBio, Inc. 504.45 Million USD 96.126%
Korro Bio, Inc. 221.66 Million USD 91.184%
Kineta, Inc. 10.28 Million USD -90.069%
BioVie Inc. 25.2 Million USD 22.482%
Codexis, Inc. 136.56 Million USD 85.691%
Celularity Inc. 143.88 Million USD 86.419%
Virax Biolabs Group Limited 5.48 Million USD -256.33%
Cibus, Inc. 544.41 Million USD 96.411%
Annexon, Inc. 297.67 Million USD 93.435%
Assembly Biosciences, Inc. 137.46 Million USD 85.785%
Eyenovia, Inc. 28.77 Million USD 32.101%
Puma Biotechnology, Inc. 230.52 Million USD 91.523%
NeurAxis, Inc. 509.49 Thousand USD -3735.344%
Regulus Therapeutics Inc. 30.75 Million USD 36.452%
Compass Therapeutics, Inc. 156.87 Million USD 87.544%
TFF Pharmaceuticals, Inc. 12.02 Million USD -62.472%
IN8bio, Inc. 33.7 Million USD 42.03%
DiaMedica Therapeutics Inc. 54.16 Million USD 63.92%
Vera Therapeutics, Inc. 175.54 Million USD 88.868%
Lumos Pharma, Inc. 40.63 Million USD 51.914%
Liquidia Corporation 120.43 Million USD 83.774%
Mustang Bio, Inc. 17.74 Million USD -10.14%
Quantum-Si incorporated 298.25 Million USD 93.448%
Arbutus Biopharma Corporation 144.4 Million USD 86.468%
enGene Holdings Inc. Common Stock 86.95 Million USD 77.528%
ARS Pharmaceuticals, Inc. 233.18 Million USD 91.62%
180 Life Sciences Corp. 5.25 Million USD -271.539%
Vaxcyte, Inc. 1.4 Billion USD 98.612%
Xenon Pharmaceuticals Inc. 964.79 Million USD 97.975%
Estrella Immunopharma, Inc. 4.45 Million USD -338.711%
NKGen Biotech, Inc. Warrants 34.77 Million USD 43.804%
Opiant Pharmaceuticals, Inc. 70.42 Million USD 72.254%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -128.266%
Soleno Therapeutics, Inc. 180.69 Million USD 89.185%
PepGen Inc. 143.05 Million USD 86.34%
Moleculin Biotech, Inc. 38.21 Million USD 48.868%
Solid Biosciences Inc. 164.93 Million USD 88.153%
Palisade Bio, Inc. 14.05 Million USD -39.062%
Nutriband Inc. 7.51 Million USD -159.952%
Conduit Pharmaceuticals Inc. 7.22 Million USD -170.501%
Immuneering Corporation 102.58 Million USD 80.951%
Belite Bio, Inc 94.64 Million USD 79.353%
CG Oncology, Inc. Common stock 199.3 Million USD 90.195%
GeoVax Labs, Inc. 9.28 Million USD -110.498%
Tourmaline Bio, Inc. 210.29 Million USD 90.708%
Altimmune, Inc. 210.64 Million USD 90.723%
Peak Bio, Inc. 2.59 Million USD -652.615%
SeaStar Medical Holding Corporation 3.51 Million USD -456.248%
FibroBiologics, Inc. Common Stock 11.82 Million USD -65.308%
Neurogene Inc. 222.57 Million USD 91.22%
Mirum Pharmaceuticals, Inc. 646.62 Million USD 96.978%
Kintara Therapeutics, Inc. 6.2 Million USD -215.076%
CARGO Therapeutics, Inc. Common Stock 453.03 Million USD 95.687%
Sesen Bio, Inc. 189.17 Million USD 89.67%
argenx SE 4.54 Billion USD 99.57%
NKGen Biotech, Inc. Common Stock 34.77 Million USD 43.804%
Dianthus Therapeutics, Inc. 179.4 Million USD 89.108%
Immunome, Inc. 148.54 Million USD 86.845%
Enveric Biosciences, Inc. 6.11 Million USD -219.429%
Design Therapeutics, Inc. 289.64 Million USD 93.253%
Seelos Therapeutics, Inc. 5.41 Million USD -260.668%
Enliven Therapeutics, Inc. 271.86 Million USD 92.812%
Iovance Biotherapeutics, Inc. 780.35 Million USD 97.496%
Taysha Gene Therapies, Inc. 266.99 Million USD 92.681%
Inovio Pharmaceuticals, Inc. 172.94 Million USD 88.701%
Athira Pharma, Inc. 160.24 Million USD 87.806%
XOMA Corporation 234.3 Million USD 91.66%
Merus N.V. 458.49 Million USD 95.738%
Quince Therapeutics, Inc. 180.2 Million USD 89.156%
Rezolute, Inc. 132.73 Million USD 85.278%
Clene Inc. 52.34 Million USD 62.666%
Indaptus Therapeutics, Inc. 14.92 Million USD -30.938%
BeyondSpring Inc. 24.8 Million USD 21.231%
Synlogic, Inc. 75.55 Million USD 74.135%
Allarity Therapeutics, Inc. 11.86 Million USD -64.736%
Phio Pharmaceuticals Corp. 9.36 Million USD -108.682%
Peak Bio, Inc. 2.59 Million USD -652.615%
Werewolf Therapeutics, Inc. 174.83 Million USD 88.823%
Krystal Biotech, Inc. 818.35 Million USD 97.612%
Karyopharm Therapeutics Inc. 240.43 Million USD 91.873%
SpringWorks Therapeutics, Inc. 725.78 Million USD 97.308%
Lipella Pharmaceuticals Inc. 3.57 Million USD -446.269%
MannKind Corporation 475.19 Million USD 95.888%
Ikena Oncology, Inc. 192.09 Million USD 89.827%
Cyclerion Therapeutics, Inc. 13.37 Million USD -46.112%
Gyre Therapeutics, Inc. 116.53 Million USD 83.232%
Gossamer Bio, Inc. 311.91 Million USD 93.735%
CohBar, Inc. 16.36 Million USD -19.402%
Cognition Therapeutics, Inc. 35.16 Million USD 44.427%
NRx Pharmaceuticals, Inc. 7.31 Million USD -167.136%
Legend Biotech Corporation 1.84 Billion USD 98.943%
Mural Oncology plc 301.74 Million USD 93.524%
Disc Medicine, Inc. 367.99 Million USD 94.69%
Champions Oncology, Inc. 26.13 Million USD 25.222%
REGENXBIO Inc. 573.97 Million USD 96.595%
Ensysce Biosciences, Inc. 2.7 Million USD -621.58%
Anavex Life Sciences Corp. 154.38 Million USD 87.343%
Cellectar Biosciences, Inc. 12.07 Million USD -61.822%
Edgewise Therapeutics, Inc. 340.03 Million USD 94.253%
Vaxart, Inc. 91.83 Million USD 78.72%
PharmaCyte Biotech, Inc. 59.9 Million USD 67.379%
Aldeyra Therapeutics, Inc. 148.32 Million USD 86.826%
Cellectis S.A. 334.27 Million USD 94.154%
Longeveron Inc. 12.17 Million USD -60.461%
Repare Therapeutics Inc. 253.9 Million USD 92.304%
Sarepta Therapeutics, Inc. 3.26 Billion USD 99.401%
Inozyme Pharma, Inc. 200.84 Million USD 90.271%
Revolution Medicines, Inc. 2.08 Billion USD 99.064%
Nymox Pharmaceutical Corporation 1.62 Million USD -1102.523%
Third Harmonic Bio, Inc. 277.71 Million USD 92.964%
ArriVent BioPharma, Inc. Common Stock 163.09 Million USD 88.019%
AN2 Therapeutics, Inc. 138.74 Million USD 85.916%
Anixa Biosciences, Inc. 25.52 Million USD 23.435%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 99.914%
Denali Therapeutics Inc. 1.15 Billion USD 98.307%
Revelation Biosciences, Inc. 12.21 Million USD -60.007%
Veru Inc. 50.59 Million USD 61.378%
Corvus Pharmaceuticals, Inc. 45.55 Million USD 57.103%
Cingulate Inc. 3.49 Million USD -459.684%
Passage Bio, Inc. 150.54 Million USD 87.02%
Context Therapeutics Inc. 16.06 Million USD -21.654%
Exicure, Inc. 11.58 Million USD -68.748%
Day One Biopharmaceuticals, Inc. 376.04 Million USD 94.804%
Oramed Pharmaceuticals Inc. 161.64 Million USD 87.911%
Scinai Immunotherapeutics Ltd. 17.47 Million USD -11.842%
Nuvalent, Inc. 732.38 Million USD 97.332%
ABVC BioPharma, Inc. 14.94 Million USD -30.761%
Carisma Therapeutics, Inc. 89.55 Million USD 78.18%
Unicycive Therapeutics, Inc. 14.19 Million USD -37.7%
OmniAb, Inc. 401.98 Million USD 95.139%
Anew Medical, Inc. 19.45 Million USD -0.437%
Fennec Pharmaceuticals Inc. 26.72 Million USD 26.885%
Lipocine Inc. 23 Million USD 15.043%
Lexeo Therapeutics, Inc. Common Stock 139.8 Million USD 86.023%
Nautilus Biotechnology, Inc. 305.56 Million USD 93.605%
SAB Biotherapeutics, Inc. 83.94 Million USD 76.721%
G1 Therapeutics, Inc. 121.54 Million USD 83.922%
Bellerophon Therapeutics, Inc. 7.93 Million USD -146.263%
Sage Therapeutics, Inc. 882.27 Million USD 97.785%
Ocugen, Inc. 64.54 Million USD 69.726%
Mind Medicine (MindMed) Inc. 124.54 Million USD 84.31%
Q32 Bio Inc. 306.11 Million USD 93.617%
Brainstorm Cell Therapeutics Inc. 4.2 Million USD -364.377%
Alumis Inc. Common Stock 89.61 Million USD 78.194%
Equillium, Inc. 50.53 Million USD 61.328%
Kyverna Therapeutics, Inc. 75.19 Million USD 74.013%
Coya Therapeutics, Inc. 41.27 Million USD 52.655%
CNS Pharmaceuticals, Inc. 1.7 Million USD -1048.894%
Dominari Holdings Inc. 57.55 Million USD 66.05%
Edesa Biotech, Inc. 8.89 Million USD -119.798%
vTv Therapeutics Inc. 11.01 Million USD -77.355%
Bio-Techne Corporation 2.81 Billion USD 99.305%
Agios Pharmaceuticals, Inc. 937.11 Million USD 97.915%
Harmony Biosciences Holdings, Inc. 811.44 Million USD 97.592%
Prelude Therapeutics Incorporated 277.66 Million USD 92.962%
Candel Therapeutics, Inc. 41.7 Million USD 53.141%
iTeos Therapeutics, Inc. 667.58 Million USD 97.073%
Nkarta, Inc. 378.88 Million USD 94.842%
BioCardia, Inc. 2.98 Million USD -554.202%
Iterum Therapeutics plc 26.25 Million USD 25.584%